Click here for Nimenrix® (meningococcal groups A, C, W-135 and Y conjugate vaccine) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.
Nimenrix (meningococcal groups A, C, W-135 and Y conjugate vaccine) is indicated for active immunisation of individuals from the age of 6 weeks against invasive meningococcal disease caused by Neisseria meningitidis groups A, C, W-135 and Y.1
Invasive meningococcal disease (IMD) is primarily associated with meningitis and septicaemia which can be fatal or have long-term consequences, even with appropriate medical care.2,3
Certain behaviours in specific age groups are associated with an increased risk of invasive meningococcal disease:
Nimenrix is recommended in the routine immunisation schedule and is offered to teenagers aged 13-15 years old in school years 9 and 10.8,9
Some young adults today may not have received a MenACWY vaccination for which they are eligible.
If your patients were born on or after 1 September 1996 and are eligible but missed their teenage MenACWY vaccine, they can still have the vaccine up to their 25th birthday. If they are starting university for the first time, they can still have the vaccine up to their 25th birthday.9,10
These 3 simple steps can help protect your patients who are still eligible to receive a MenACWY vaccine:
Find out about your patient’s vaccination history:
“You may have missed out on the MenACWY vaccination programme. Have you had your MenACWY vaccine?”
If attempts to establish whether or not MenACWY vaccine has been administered are unsuccessful, individuals should be assumed to be unimmunised and MenACWY vaccination should be offered to those eligible to receive it.11
Advise of the risks, especially for young adults:
“Young people are at higher risk of contracting invasive meningococcal disease compared to some other age groups.”12
Help protect adolescents and young adults against invasive meningococcal disease caused by serogroups A,C,W and Y with a single dose of Nimenrix.1
Nimenrix is also recommended for patients with specific medical conditions, these include those with:8
Contact our Pfizer Vaccines UK team
Visit our patient websites page for information about our patient support websites
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020